The notion of 'Utilisation' in the Nagoya Protocol and the EU ABS regulation for the upstream actors

This consultancy identifies the particular challenges that upstream actors face with regard to the EU-level implementation of the Nagoya Protocol on Access to Genetic Resources and Benefit-sharing (ABS). Notably, the consultancy investigates the questions of upstream actors regarding the precise subject-matter scope of the Nagoya Protocol and the EU ABS Regulation and applicable obligations to the particular activities that are conducted in the upstream part of the value chain. These questions are identified on the basis of a deskbased review of academic literature and a series of semi-structured interviews with upstream stakeholders.